* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1
Deoxyribozyme wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Human genetic variation wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Genetic testing wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Non-coding DNA wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Genome editing wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genome (book) wikipedia , lookup
Medical genetics wikipedia , lookup
Public health genomics wikipedia , lookup
Designer baby wikipedia , lookup
Microevolution wikipedia , lookup
Genetic engineering wikipedia , lookup
Genetic Repositories Australia BACKGROUND GRA supported by an NHMRC Enabling Facility Grant awarded in 2006. Chief Investigators on the NHMRC Enabling Grant are – Professor Peter Schofield (Prince of Wales Medical Research Institute & University of New South Wales) Dr Juleen Cavanaugh (Australian National University, Medical School, Canberra Hospital) Dr Susan Forrest (Australian Genome Research Facility) Professor John Hopper (Centre for Genetic Epidemiology University of Melbourne) GRA is based at the Prince of Wales Medical Research Institute in Sydney. Facility Manager is Mr Steve Turner. GRA - Aims and Objectives GRA aims to provide a central national facility for – • establishing • distributing and • maintaining the long-term secure storage of human genetic samples from a variety of sources. GRA aims to facilitate world-class collaborative health and medical research in Australia, and internationally through: the provision of clinically validated but de-identified patient material complete phenotypic descriptors of disease and family, or cohort structure permits genetic analyses for disease gene identification. GRA - Services A central facility for the processing of blood samples and production of B-lymphoblastoid cell lines. Extraction of DNA from blood or cell lines. Samples will be processed from patients, controls and epidemiological participants from studies on a range of diseases and their outcomes. DNA and immortalized cell lines will be stored for distribution to qualified investigators. Samples available for distribution will be processed at a subsidised academic rate. Fee-for-service work can be performed for samples not available for distribution. GRA FURTHER INFORMATION Mr Steve Turner, Facility Manager (GRA) Prince of Wales Medical Research Institute Randwick, Sydney, Email: [email protected] Telephone: (+ 61 2) 9399 1068 Website: www.powmri.edu.au/gra.htm The ARCBS Aussie Normals 1000 ARCBS blood donors – healthy Caucasians Cell lines & DNA DNA available in 96 well plates from mid April 2007 Biochemical phenotype available via collaboration with researchers (Cavanaugh & Hickman @ ANU) Projects subject to approval by ARCBS AGRF Services SNP Discovery Genotyping Expression analysis